Picture of CSPC Pharmaceutical logo

1093 CSPC Pharmaceutical Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

Annual cashflow statement for CSPC Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
C2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line6,8477,5827,3895,5794,808
Depreciation
Amortisation
Non-Cash Items-545-46516.2130-700
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-2,529-536-4,341-2,510314
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities4,6377,6274,1794,5355,832
Capital Expenditures-1,758-2,723-1,893-2,679-2,280
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items1,121-4,0732,759-1,179-1,598
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-637-6,796866-3,858-3,878
Financing Cash Flow Items-20.2342792194427
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-2,197-1,904-2,560-5,253-2,612
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1,800-1,0592,490-4,573-663